Hain Celestial Group (NASDAQ:HAIN) reported quarterly earnings of $0.39 per share which met the analyst consensus estimate. This is a 21.88 percent increase over earnings of $0.32 per share from the same period last year. The company reported quarterly sales of $450.70 million which missed the analyst consensus estimate of $459.23 million by 1.86 percent. This is a 11.93 percent decrease over sales of $511.75 million the same period last year.
Morgan Stanley Maintains Overweight on Atea Pharmaceuticals, Raises Price Target to $37
Morgan Stanley analyst Matthew Harrison maintains Atea Pharmaceuticals (NASDAQ:AVIR) with a Overweight and raises the price target from $35 to $37.
